{"entity":{"type":"insider","cik":"0001586835","url":"/insider/0001586835","json_url":"/insider/0001586835.json","name":"Kumar Ravindra","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":25,"first":"2014-04-24","last":"2019-09-10","span_basis":"filed_date"},"name_variants":[{"name":"Kumar Ravindra","source":"filing","n_filings":25,"first_seen":"2014-04-24","last_seen":"2019-09-10"}],"transactions":[{"id":8410419,"accession":"0001179110-19-010222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-010222","line_url":"/filing/0001179110-19-010222#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3389.0,"shares_display":"3,389","price_per_share":45.24,"price_display":"45.24","price_state":"stated","total_value":153318.36,"total_display":"153,318.36","total_whole":"153,318","shares_owned_after":86986.0,"shares_owned_after_display":"86,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-10","scope":"insider"},{"id":8039137,"accession":"0001179110-19-004913","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-19-004913","line_url":"/filing/0001179110-19-004913","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3622.0,"shares_display":"3,622","price_per_share":44.63584759801215,"price_display":"44.64","price_state":"stated","total_value":161671.04,"total_display":"161,671.04","total_whole":"161,671","shares_owned_after":90545.0,"shares_owned_after_display":"90,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-11","scope":"insider","n_lines":3},{"id":8187161,"accession":"0001179110-19-000470","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-19-000470","line_url":"/filing/0001179110-19-000470","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5788.0,"shares_display":"5,788","price_per_share":42.94162232204561,"price_display":"42.94","price_state":"stated","total_value":248546.11,"total_display":"248,546.11","total_whole":"248,546","shares_owned_after":90521.0,"shares_owned_after_display":"90,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":3},{"id":6750454,"accession":"0001179110-18-005399","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-005399","line_url":"/filing/0001179110-18-005399","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1203.0,"shares_display":"1,203","price_per_share":38.408162926018285,"price_display":"38.41","price_state":"stated","total_value":46205.02,"total_display":"46,205.02","total_whole":"46,205","shares_owned_after":96035.0,"shares_owned_after_display":"96,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-03","filed_date":"2018-04-04","scope":"insider","n_lines":2},{"id":5985466,"accession":"0001179110-18-000548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-000548","line_url":"/filing/0001179110-18-000548#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":42.41,"price_display":"42.41","price_state":"stated","total_value":182363.0,"total_display":"182,363.00","total_whole":"182,363","shares_owned_after":92675.0,"shares_owned_after_display":"92,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":5097626,"accession":"0001179110-17-012290","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-17-012290","line_url":"/filing/0001179110-17-012290#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":38.12,"price_display":"38.12","price_state":"stated","total_value":304.96,"total_display":"304.96","total_whole":"305","shares_owned_after":90214.0,"shares_owned_after_display":"90,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-14","scope":"insider"},{"id":5097623,"accession":"0001179110-17-012290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-012290","line_url":"/filing/0001179110-17-012290","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5105.0,"shares_display":"5,105","price_per_share":38.415778648383935,"price_display":"38.42","price_state":"stated","total_value":196112.55,"total_display":"196,112.55","total_whole":"196,113","shares_owned_after":90722.0,"shares_owned_after_display":"90,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-14","scope":"insider","n_lines":2},{"id":5029498,"accession":"0001179110-17-011284","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-011284","line_url":"/filing/0001179110-17-011284#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13065.0,"shares_display":"13,065","price_per_share":35.41,"price_display":"35.41","price_state":"stated","total_value":462631.65,"total_display":"462,631.65","total_whole":"462,632","shares_owned_after":95327.0,"shares_owned_after_display":"95,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-08","filed_date":"2017-08-09","scope":"insider"},{"id":4773238,"accession":"0001179110-17-010227","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-010227","line_url":"/filing/0001179110-17-010227#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":937.0,"shares_display":"937","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":29984.0,"total_display":"29,984.00","total_whole":"29,984","shares_owned_after":95327.0,"shares_owned_after_display":"95,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-07","scope":"insider"},{"id":4967909,"accession":"0001179110-17-000684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-000684","line_url":"/filing/0001179110-17-000684","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":27.458195,"price_display":"27.46","price_state":"stated","total_value":54916.39,"total_display":"54,916.39","total_whole":"54,916","shares_owned_after":88427.0,"shares_owned_after_display":"88,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-06","scope":"insider","n_lines":2},{"id":3196090,"accession":"0001179110-16-030648","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001179110-16-030648","line_url":"/filing/0001179110-16-030648#line-14","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16833.0,"shares_display":"16,833","price_per_share":34.14,"price_display":"34.14","price_state":"stated","total_value":574678.62,"total_display":"574,678.62","total_whole":"574,679","shares_owned_after":75866.0,"shares_owned_after_display":"75,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-10","filed_date":"2016-10-11","scope":"insider"},{"id":3196080,"accession":"0001179110-16-030648","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001179110-16-030648","line_url":"/filing/0001179110-16-030648","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19644.0,"shares_display":"19,644","price_per_share":33.370897984117285,"price_display":"33.37","price_state":"stated","total_value":655537.92,"total_display":"655,537.92","total_whole":"655,538","shares_owned_after":75894.0,"shares_owned_after_display":"75,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-07","filed_date":"2016-10-11","scope":"insider","n_lines":2},{"id":3196059,"accession":"0001179110-16-030648","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-16-030648","line_url":"/filing/0001179110-16-030648","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16009.0,"shares_display":"16,009","price_per_share":34.375330126803675,"price_display":"34.38","price_state":"stated","total_value":550314.66,"total_display":"550,314.66","total_whole":"550,315","shares_owned_after":77427.0,"shares_owned_after_display":"77,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-11","scope":"insider","n_lines":2},{"id":8395380,"accession":"0001104659-15-065569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-065569","line_url":"/filing/0001104659-15-065569#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":1155000.0,"total_display":"1,155,000.00","total_whole":"1,155,000","shares_owned_after":56685.0,"shares_owned_after_display":"56,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-16","scope":"insider"},{"id":8915976,"accession":"0001179110-15-004403","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-15-004403","line_url":"/filing/0001179110-15-004403","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":40.908956363636364,"price_display":"40.91","price_state":"stated","total_value":224999.26,"total_display":"224,999.26","total_whole":"224,999","shares_owned_after":36614.0,"shares_owned_after_display":"36,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-06","scope":"insider","n_lines":6},{"id":8791462,"accession":"0001179110-15-001829","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-001829","line_url":"/filing/0001179110-15-001829","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":38.67852727272727,"price_display":"38.68","price_state":"stated","total_value":212731.9,"total_display":"212,731.90","total_whole":"212,732","shares_owned_after":37635.0,"shares_owned_after_display":"37,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider","n_lines":4},{"id":8178962,"accession":"0001179110-15-000832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-000832","line_url":"/filing/0001179110-15-000832","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":40.80133333333333,"price_display":"40.80","price_state":"stated","total_value":61202.0,"total_display":"61,202.00","total_whole":"61,202","shares_owned_after":36200.0,"shares_owned_after_display":"36,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-13","scope":"insider","n_lines":2},{"id":8862410,"accession":"0001179110-15-000346","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-000346","line_url":"/filing/0001179110-15-000346","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":38.461,"price_display":"38.46","price_state":"stated","total_value":153844.0,"total_display":"153,844.00","total_whole":"153,844","shares_owned_after":38100.0,"shares_owned_after_display":"38,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider","n_lines":2},{"id":6455619,"accession":"0001179110-14-017420","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-017420","line_url":"/filing/0001179110-14-017420","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":35.88425,"price_display":"35.88","price_state":"stated","total_value":143537.0,"total_display":"143,537.00","total_whole":"143,537","shares_owned_after":29990.0,"shares_owned_after_display":"29,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider","n_lines":3},{"id":7006505,"accession":"0001179110-14-016618","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-016618","line_url":"/filing/0001179110-14-016618#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":27890.0,"shares_owned_after_display":"27,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-14","scope":"insider"},{"id":7006500,"accession":"0001179110-14-016618","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-016618","line_url":"/filing/0001179110-14-016618","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.12,"price_display":"33.12","price_state":"stated","total_value":132480.0,"total_display":"132,480.00","total_whole":"132,480","shares_owned_after":29890.0,"shares_owned_after_display":"29,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider","n_lines":2},{"id":6721339,"accession":"0001179110-14-014744","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-014744","line_url":"/filing/0001179110-14-014744","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":29.69008,"price_display":"29.69","price_state":"stated","total_value":118760.32,"total_display":"118,760.32","total_whole":"118,760","shares_owned_after":30498.0,"shares_owned_after_display":"30,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-01","scope":"insider","n_lines":2},{"id":6721330,"accession":"0001179110-14-014744","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-014744","line_url":"/filing/0001179110-14-014744#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":29890.0,"shares_owned_after_display":"29,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-01","scope":"insider"},{"id":6428854,"accession":"0001179110-14-013699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-013699","line_url":"/filing/0001179110-14-013699#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":26.4,"price_display":"26.40","price_state":"stated","total_value":52800.0,"total_display":"52,800.00","total_whole":"52,800","shares_owned_after":31890.0,"shares_owned_after_display":"31,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6334387,"accession":"0001179110-14-012955","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-012955","line_url":"/filing/0001179110-14-012955","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":29.966666666666665,"price_display":"29.97","price_state":"stated","total_value":269700.0,"total_display":"269,700.00","total_whole":"269,700","shares_owned_after":31890.0,"shares_owned_after_display":"31,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-14","filed_date":"2014-08-15","scope":"insider","n_lines":2},{"id":6904006,"accession":"0001179110-14-011385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-011385","line_url":"/filing/0001179110-14-011385#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586835","owner_name":"Kumar Ravindra","owner_display_name":"Kumar Ravindra","owner_url":"/insider/0001586835","role":"Officer (VP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":34.1,"price_display":"34.10","price_state":"stated","total_value":68200.0,"total_display":"68,200.00","total_whole":"68,200","shares_owned_after":35890.0,"shares_owned_after_display":"35,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"}],"collapsed":true,"next_cursor":"2014-07-01|6904006","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Officer (SVP & Chief Scientific Officer)","n_filings":25,"first_seen":"2014-04-24","last_seen":"2019-09-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586835","retrieved_at":"2026-08-25T21:08:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}